Search Results for "Avesthagen Limited Cosmosid"

22:42 EDT 4th July 2015 | BioPortfolio

Matching Channels

None

Matching News

Avesthagen to introduce migraine gene therapy with Australian technology

Biospectrum Severe sufferers of migraine could get some relief with Avesthagen in licensing a gene-based solution devel...

Australia-India collaboration aims to make migraine therapy a reality

(Queensland University of Technology) A collaboration between QUT (Queensland University of Technology) and Indian life science company, Avesthagen Limited, is paving the way for migraine genetics res...

Biosimilars in Emerging Markets

Recently added to the BioPortfolio report store, Biosimilars in Emerging Markets is a new report from Firstword published on 2015-04-26. This 226-page report is available from $665. What are the imp...

Chemotherapy Induced Anemia - Pipeline Review, H1 2015

Recently added to the BioPortfolio report store, Chemotherapy Induced Anemia - Pipeline Review, H1 2015 is a new report from Global Markets Direct published on 2015-02-17. This 54-page report is avai...

Pharma Leader Series: Top 25 Biosimilar Drug Manufacturers 2015-2025

LONDON, April 2, 2015 /PRNewswire/ -- Biosimilar drug producers - your guide to those companies' activities and prospects What does the future hold for makers of biosimilar medicines? ...

Matching PubMed Articles

None

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement